GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.
复制标题
DOI:
10.1016/j.celrep.2022.111344
复制
发表时间:
2022-09-20
期刊:
影响因子:
8.8
通讯作者:
Costello, Joseph F.
中科院分区:
文献类型:
--
作者:
McKinney, Andrew M.;Mathur, Radhika;Stevers, Nicholas O.;Molinaro, Annette M.;Chang, Susan M.;Phillips, Joanna J.;Costello, Joseph F.
Telomerase activation counteracts senescence and telomere erosion caused by uncontrolled proliferation. Epidermal growth factor receptor (EGFR) amplification drives proliferation while telomerase reverse transcriptase promoter (TERTp) mutations underlie telomerase reactivation through recruitment of GA-binding protein (GABP). EGFR amplification and TERTp mutations typically co-occur in glioblastoma, the most common and aggressive primary brain tumor. To determine if these two frequent alterations driving proliferation and immortality are functionally connected, we combine analyses of copy number, mRNA, and protein data from tumor tissue with pharmacologic and genetic perturbations. We demonstrate that proliferation arrest decreases TERT expression in a GABP-dependent manner and elucidate a critical proliferation-to-immortality pathway from EGFR to TERT expression selectively from the mutant TERTp through activation of AMP-mediated kinase (AMPK) and GABP upregulation. EGFR-AMPK signaling promotes telomerase activity and maintains telomere length. These results define how the tumor cell immortality mechanism keeps pace with persistent oncogene signaling and cell cycling. TERT promoter mutations are common in human cancer and confer cellular immortality. McKinney et al. describe the interaction between TERT promoter mutations, EGFR amplification, and the cell cycle in glioblastoma. The results demonstrate how proliferation drivers cooperate with telomere maintenance mechanisms to counteract telomere shortening caused by unlimited cell division.
登录
查看更多内容
影响因子:
16.6
作者:
Han F;Li CF;Cai Z;Zhang X;Jin G;Zhang WN;Xu C;Wang CY;Morrow J;Zhang S;Xu D;Wang G;Lin HK
通讯作者:
Lin HK
影响因子:
7.3
作者:
Gao J;Aksoy BA;Dogrusoz U;Dresdner G;Gross B;Sumer SO;Sun Y;Jacobsen A;Sinha R;Larsson E;Cerami E;Sander C;Schultz N
通讯作者:
Schultz N
DOI:
10.1056/nejmoa1407279
发表时间:
2015-06-25
期刊:
The New England journal of medicine
影响因子:
--
作者:
Eckel-Passow JE;Lachance DH;Molinaro AM;Walsh KM;Decker PA;Sicotte H;Pekmezci M;Rice T;Kosel ML;Smirnov IV;Sarkar G;Caron AA;Kollmeyer TM;Praska CE;Chada AR;Halder C;Hansen HM;McCoy LS;Bracci PM;Marshall R;Zheng S;Reis GF;Pico AR;O'Neill BP;Buckner JC;Giannini C;Huse JT;Perry A;Tihan T;Berger MS;Chang SM;Prados MD;Wiemels J;Wiencke JK;Wrensch MR;Jenkins RB
通讯作者:
Jenkins RB
影响因子:
15.9
作者:
Fouse, Shaun D.;Nakamura, Jean L.;Costello, Joseph F.
通讯作者:
Costello, Joseph F.
DOI:
10.1073/pnas.2008772118
发表时间:
2021-03-30
影响因子:
11.1
作者:
Amen AM;Fellmann C;Soczek KM;Ren SM;Lew RJ;Knott GJ;Park JE;McKinney AM;Mancini A;Doudna JA;Costello JF
通讯作者:
Costello JF